Covered recipient · General Payments record
MELISSA M DAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,639.80
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $443.78 | 33 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $166.09 | 5 |
| ABBVIE INC. | $163.06 | 17 |
| Lilly USA, LLC | $53.64 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.03 | 2 |
| PFIZER INC. | $29.18 | 2 |
| Mylan Specialty L.P. | $27.89 | 1 |
| Dermavant Sciences, Inc. | $22.54 | 1 |
| Novo Nordisk AS | $15.56 | 1 |
| Acerta Pharma LLC | $15.49 | 1 |
| Daiichi Sankyo Inc. | $15.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.73 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994668 | CMS |
| ABBVIE INC. | $4.09 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994670 | CMS |
| ABBVIE INC. | $18.43 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994672 | CMS |
| ABBVIE INC. | $21.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994674 | CMS |
| ABBVIE INC. | $7.61 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994676 | CMS |
| ABBVIE INC. | $3.82 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994678 | CMS |
| ABBVIE INC. | $28.37 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994680 | CMS |
| ABBVIE INC. | $4.11 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994682 | CMS |
| ABBVIE INC. | $4.78 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994684 | CMS |
| ABBVIE INC. | $4.27 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994686 | CMS |
| ABBVIE INC. | $4.89 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994688 | CMS |
| ABBVIE INC. | $4.09 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994690 | CMS |
| ABBVIE INC. | $17.53 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994692 | CMS |
| ABBVIE INC. | $2.13 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994694 | CMS |
| ABBVIE INC. | $4.95 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994696 | CMS |
| ABBVIE INC. | $5.42 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994698 | CMS |
| ABBVIE INC. | $21.42 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106994700 | CMS |
| Astellas Pharma US Inc | $18.04 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139478580 | CMS |
| Astellas Pharma US Inc | $99.00 | 03/14/2024 | Education | Undisputed | 01/23/2026 | 1139504971 | CMS |
| Astellas Pharma US Inc | $17.18 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139465802 | CMS |
| Astellas Pharma US Inc | $17.06 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139529390 | CMS |
| Astellas Pharma US Inc | $14.81 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139551607 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.49 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105396588 | CMS |
| Daiichi Sankyo Inc. | $15.30 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089413849 | CMS |
| Dermavant Sciences, Inc. | $22.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127966804 | CMS |
| Lilly USA, LLC | $20.59 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135757932 | CMS |
| Lilly USA, LLC | $14.04 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135829706 | CMS |
| Lilly USA, LLC | $19.01 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135831544 | CMS |
| Mylan Specialty L.P. | $27.89 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147285882 | CMS |
| Novartis Pharmaceuticals Corporation | $16.73 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086951611 | CMS |
| Novartis Pharmaceuticals Corporation | $17.30 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086951633 | CMS |
| Novo Nordisk Inc | $15.56 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100312201 | CMS |
| PFIZER INC. | $16.05 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131135565 | CMS |
| PFIZER INC. | $13.13 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131970100 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.